Cargando…

Impact of initial dialysis modality on mortality: a propensity-matched study

BACKGROUND: Whether the choice of dialysis modality in patients with end stage renal disease may impact mortality is undecided. No randomized controlled trial has properly addressed this issue. Propensity-matched observational studies could give important insight into the independent effect of perit...

Descripción completa

Detalles Bibliográficos
Autores principales: Waldum-Grevbo, Bård, Leivestad, Torbjørn, Reisæter, Anna V, Os, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628291/
https://www.ncbi.nlm.nih.gov/pubmed/26519164
http://dx.doi.org/10.1186/s12882-015-0175-5
_version_ 1782398422464069632
author Waldum-Grevbo, Bård
Leivestad, Torbjørn
Reisæter, Anna V
Os, Ingrid
author_facet Waldum-Grevbo, Bård
Leivestad, Torbjørn
Reisæter, Anna V
Os, Ingrid
author_sort Waldum-Grevbo, Bård
collection PubMed
description BACKGROUND: Whether the choice of dialysis modality in patients with end stage renal disease may impact mortality is undecided. No randomized controlled trial has properly addressed this issue. Propensity-matched observational studies could give important insight into the independent effect of peritoneal (PD) opposed to haemodialysis (HD) on all-cause and cardiovascular mortality. METHODS: To correct for case-mix differences between patients treated with PD and HD, propensity-matched analyses were utilized in all patients who initiated dialysis as first renal replacement therapy in Norway in the period 2005–2012. PD patients were matched in a 1:1 fashion with HD patients, creating 692 pairs of patients with comparable baseline variables. As-treated and intention-to treat analyses were undertaken to assess cardiovascular and all-cause mortality. Interaction analyses were used to assess differences in the relationship between initial dialysis modality and mortality, between strata of age, gender and prevalent diabetes mellitus. RESULTS: In the as-treated analyses, initial dialysis modality did not impact 2-year (PD vs. HD: HR 0.87, 95 % CI 0.67–1.12) or 5-year all-cause mortality (HR 0.95, 95 % CI 0.77–1.17). In patients younger than 65 years, PD was superior compared to HD with regard to both 2-year (HR 0.39, 95 % CI 0.19–0.81), and 5-year all-cause mortality (HR 0.49, 95 % CI 0.27–0.89). Cardiovascular mortality was also lower in the younger patients treated with PD (5-year HR 0.38, 95 % CI 0.15–0.96). PD was not associated with impaired prognosis in any of the prespecified subgroups compared to HD. The results were similar in the as-treated and intention-to-treat analyses. CONCLUSION: Survival in PD was not inferior to HD in any subgroup of patients even after five years of follow-up. In patients below 65 years, PD yielded superior survival rates compared to HD. Increased use of PD as initial dialysis modality in ESRD patients could be encouraged.
format Online
Article
Text
id pubmed-4628291
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46282912015-11-01 Impact of initial dialysis modality on mortality: a propensity-matched study Waldum-Grevbo, Bård Leivestad, Torbjørn Reisæter, Anna V Os, Ingrid BMC Nephrol Research Article BACKGROUND: Whether the choice of dialysis modality in patients with end stage renal disease may impact mortality is undecided. No randomized controlled trial has properly addressed this issue. Propensity-matched observational studies could give important insight into the independent effect of peritoneal (PD) opposed to haemodialysis (HD) on all-cause and cardiovascular mortality. METHODS: To correct for case-mix differences between patients treated with PD and HD, propensity-matched analyses were utilized in all patients who initiated dialysis as first renal replacement therapy in Norway in the period 2005–2012. PD patients were matched in a 1:1 fashion with HD patients, creating 692 pairs of patients with comparable baseline variables. As-treated and intention-to treat analyses were undertaken to assess cardiovascular and all-cause mortality. Interaction analyses were used to assess differences in the relationship between initial dialysis modality and mortality, between strata of age, gender and prevalent diabetes mellitus. RESULTS: In the as-treated analyses, initial dialysis modality did not impact 2-year (PD vs. HD: HR 0.87, 95 % CI 0.67–1.12) or 5-year all-cause mortality (HR 0.95, 95 % CI 0.77–1.17). In patients younger than 65 years, PD was superior compared to HD with regard to both 2-year (HR 0.39, 95 % CI 0.19–0.81), and 5-year all-cause mortality (HR 0.49, 95 % CI 0.27–0.89). Cardiovascular mortality was also lower in the younger patients treated with PD (5-year HR 0.38, 95 % CI 0.15–0.96). PD was not associated with impaired prognosis in any of the prespecified subgroups compared to HD. The results were similar in the as-treated and intention-to-treat analyses. CONCLUSION: Survival in PD was not inferior to HD in any subgroup of patients even after five years of follow-up. In patients below 65 years, PD yielded superior survival rates compared to HD. Increased use of PD as initial dialysis modality in ESRD patients could be encouraged. BioMed Central 2015-10-30 /pmc/articles/PMC4628291/ /pubmed/26519164 http://dx.doi.org/10.1186/s12882-015-0175-5 Text en © Waldum-Grevbo et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Waldum-Grevbo, Bård
Leivestad, Torbjørn
Reisæter, Anna V
Os, Ingrid
Impact of initial dialysis modality on mortality: a propensity-matched study
title Impact of initial dialysis modality on mortality: a propensity-matched study
title_full Impact of initial dialysis modality on mortality: a propensity-matched study
title_fullStr Impact of initial dialysis modality on mortality: a propensity-matched study
title_full_unstemmed Impact of initial dialysis modality on mortality: a propensity-matched study
title_short Impact of initial dialysis modality on mortality: a propensity-matched study
title_sort impact of initial dialysis modality on mortality: a propensity-matched study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628291/
https://www.ncbi.nlm.nih.gov/pubmed/26519164
http://dx.doi.org/10.1186/s12882-015-0175-5
work_keys_str_mv AT waldumgrevbobard impactofinitialdialysismodalityonmortalityapropensitymatchedstudy
AT leivestadtorbjørn impactofinitialdialysismodalityonmortalityapropensitymatchedstudy
AT reisæterannav impactofinitialdialysismodalityonmortalityapropensitymatchedstudy
AT osingrid impactofinitialdialysismodalityonmortalityapropensitymatchedstudy